Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma

NCT00004148 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

NIH

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: recombinant vaccinia-B7.1 vaccine

Sponsor

National Cancer Institute (NCI)